Mapping Genome-wide Accessible Chromatin in Primary Human T Lymphocytes by ATAC-Seq
November 13th, 2017
17.7K views
Assay for Transposase-Accessible Chromatin coupled with high-throughput sequencing (ATAC-seq) is a genome-wide method to uncover accessible chromatin. This is a step-by-step ATAC-seq protocol, from molecular to the final computational analysis, optimized for human lymphocytes (Th1/Th2). This protocol can be adopted by researchers without prior experience in next-generation sequencing methods.
Overview
This article presents a step-by-step protocol for Assay for Transposase-Accessible Chromatin coupled with high-throughput sequencing (ATAC-seq), optimized for human lymphocytes. The method aims to identify accessible chromatin regions in the human genome, providing insights into the regulatory landscape of T lymphocytes.
Key Study Components
Area of Science
- Chromatin accessibility
- Epigenomics
- High-throughput sequencing
Background
- ATAC-seq is a genome-wide method to uncover accessible chromatin.
- This technique is robust and requires less starting material compared to other methods.
- It can be applied to various cell types, including cancer cells and human clinical samples.
- The protocol is designed for researchers with no prior experience in next-generation sequencing.
Purpose of Study
- To provide a comprehensive ATAC-seq protocol for human lymphocytes.
- To facilitate the identification of regulatory elements in the genome.
- To enhance understanding of chromatin accessibility in different biological contexts.
Methods Used
- Thawing and preparing human PBMCs.
- Centrifugation and processing of cells.
- High-throughput sequencing to analyze chromatin accessibility.
- Computational analysis of sequencing data.
Main Results
- Identification of accessible chromatin regions in human T lymphocytes.
- Demonstration of the robustness and efficiency of the ATAC-seq method.
- Potential applications across various cell types and organisms.
- Insights into the regulatory landscape of the human genome.
Conclusions
- ATAC-seq is a valuable tool for studying chromatin accessibility.
- The protocol can be widely adopted by researchers in the field.
- This method opens new avenues for research in epigenomics.
Frequently Asked Questions
What is ATAC-seq?
ATAC-seq is a method used to identify accessible regions of chromatin in the genome.
What are the advantages of ATAC-seq?
It is robust, requires less starting material, and provides rapid results compared to other methods.
Can ATAC-seq be applied to other cell types?
Yes, it can be applied to various human primary cells, cancer cells, and samples from other organisms.
Is prior experience in sequencing required to use this protocol?
No, the protocol is designed for researchers without prior experience in next-generation sequencing.
What insights can ATAC-seq provide?
It helps in understanding the regulatory landscape and genome-wide locations of regulatory elements.
What is the first step in the ATAC-seq protocol?
The first step involves thawing a one-milliliter aliquot of human PBMCs.
Executive Industry Relevance
Mapping genome-wide accessible chromatin in primary human T lymphocytes via ATAC-seq enables unbiased discovery of regulatory elements governing immune cell function and gene expression programs. This approach supports target validation by linking chromatin accessibility to transcription factor binding sites, providing mechanistic de-risking for immunomodulatory drug development. The method’s robustness, low input requirements, and adaptability to primary immune cells enhance its utility in early discovery workflows where predictive confidence in target biology is critical.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Identifies accessible chromatin regions that serve as regulatory DNA elements where transcription factors bind, enabling interrogation of therapeutic hypotheses in T cell-mediated pathways.
- Operational Value: Provides a sensitive, low-input alternative to DNase-seq or FAIRE-seq for profiling chromatin accessibility in primary human lymphocytes.
- Predictive Value: Supports functional target validation by revealing active regulatory landscapes that correlate with gene expression in immune contexts.
Screening & Assay Development
- Scientific Value: Generates quantitative, genome-wide chromatin accessibility profiles that can be used to screen for epigenetic states associated with immune activation or suppression.
- Operational Value: Includes built-in quality control metrics (e.g., mitochondrial read fraction, peak count, enrichment controls) to ensure assay reproducibility before sequencing.
- Scalability: Protocol is optimized for primary human immune cells and adaptable to other cell types, enabling cross-platform reuse in immune profiling pipelines.
Translational & Preclinical Research
- Translational Continuity: Enables linkage from discovery-phase chromatin states to preclinical validation by identifying regulatory elements that may serve as biomarkers or drug targets in immune diseases.
- Mechanistic De-risking: Facilitates follow-up assays (e.g., ChIP-seq) to determine which transcription factors bind open chromatin, reducing ambiguity in mechanism of action.
- Disease Relevance: Directly applicable to primary human T lymphocytes, making it suitable for modeling Th1/Th2 pathways in autoimmune, inflammatory, or oncology indications.
Pipeline & Workflow Integration
ATAC-seq fits within the discovery continuum from target hypothesis testing through lead identification to preclinical validation, particularly in immunology-focused programs where epigenetic regulation influences drug response.
- Discovery Biology: Supports hypothesis testing by mapping open chromatin regions that reflect active enhancer and promoter landscapes in primary human T cells.
- Screening: Delivers standardized, quantitative outputs (e.g., peak calling, enrichment scores) that enable comparison across conditions, genotypes, or treatments.
- Analytics: Provides nucleosome positioning and transcription factor footprinting data when integrated with motif analysis, aiding in mechanistic interpretation.
- Translational Research: Connects epigenetic states to gene expression programs, supporting biomarker alignment and pathway validation in immune-mediated disease models.
- Enterprise Reuse: Protocol is designed for adaptation across primary immune and non-immune cells, promoting standardization and reuse in immunology and immuno-oncology discovery platforms.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by linking chromatin accessibility to regulatory element activity in disease-relevant primary human lymphocytes.
- Operational Value: Requires less starting material than DNase-seq or FAIRE-seq, includes QC checkpoints, and is accessible to labs without prior NGS experience.
- Strategic Value: Informs go/no-go decisions by reducing mechanistic ambiguity in epigenetic drivers of immune cell function.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on regulatory landscape activity in human immune cells.
Implementation Considerations
- Requires expertise in primary human immune cell handling, nuclei isolation, and transposase-based tagmentation.
- Depends on access to thermal shakers, magnetic bead purification systems, and next-generation sequencing platforms.
- Necessitates cross-team standardization for cell activation protocols (e.g., Th1/Th2 polarization) and lysis buffer optimization across model systems.
- Adaptation to non-lymphocyte systems may require optimization of cell input, lysis conditions, and transposition timing.
- Practical limitations include sensitivity to cell viability and nuclei integrity, which must be monitored during isolation to prevent confounding signals.
Biopharma FAQs
Why does mitochondrial read enrichment matter in ATAC-seq QC?
High mitochondrial DNA reads indicate poor nuclei isolation or cell damage, which can confound chromatin accessibility signals; the protocol considers libraries acceptable only if 6–20% of reads map to the mitochondrial genome.
How does primer pair enrichment validate ATAC-seq library quality?
Enrichment of positive control primer pairs (at least 25-fold for pair three, 75-fold for pair four) relative to negative controls confirms successful transposition and library amplification before sequencing.
What peak count threshold indicates a successful ATAC-seq library?
Obtaining 1,000 to 2,000 peaks after initial sequencing (10 million reads) and passing FastQC parameters suggests sufficient signal-to-noise for deeper sequencing (>30 million reads).
Why is nuclei isolation critical for accurate ATAC-seq results in primary T lymphocytes?
Intact nuclei are required for efficient transposition; disruption during lysis can lead to mitochondrial DNA contamination or loss of true chromatin accessibility signals.
What statistical threshold supports proceeding to deep sequencing after initial ATAC-seq run?
Libraries must pass FastQC quality checks, show 1,000–2,000 peaks from peak calling, and exhibit adequate primer enrichment to justify sequencing beyond 30 million reads for enhanced resolution.
Chapters in this video
0:05
Title
0:54
Purification of Naïve Human CD4+ Cells, Polarization to Th1 and TH2 Cells, and Nuclei Extraction
3:18
Transposition Reaction and Library Amplification
4:33
Size Selection of ATAC-seq Libraries
6:48
Results: Quality Control and Next Generation Sequencing Reads
8:07
Conclusion
